VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | -94.1% | 20,000 | 0.0% | 0.00% | -90.0% |
| Q2 2017 | $17,000 | +142.9% | 20,000 | 0.0% | 0.01% | +150.0% |
| Q1 2017 | $7,000 | -81.1% | 20,000 | 0.0% | 0.00% | -87.5% |
| Q4 2016 | $37,000 | -66.4% | 20,000 | 0.0% | 0.03% | -44.8% |
| Q2 2016 | $110,000 | -54.4% | 20,000 | 0.0% | 0.06% | -70.9% |
| Q1 2016 | $241,000 | – | 20,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |